[Autoantibodies to nerve growth factor and astroglial protein S-100 in Rett's syndrome]. / Autoantitela k faktoru rosta nervov i astrotsitarnomu belku S-100 pri sindrome Retta.

The levels of autoantibodies (AAB) to nerve growth factor (NGF) and to S-100 protein were examined in blood of both mentally normal girls and girls with Rett's syndrome (RS). The elevated titer of anti-NGF AAB, but not of anti-S-100 AAB was determined in the blood of patients with RS. There was relative individual stability of anti-NGF AAB level which didn't depend on the stage of the disease. At the same time, a reverse correlation was found between the level of these antibodies and severity of the disease: the mild form of the disease (with relative preservation of the speech elements and locomotor functions as well as with the later age of the onset of the disease and the later development of the regressive symptoms) is characterized by the higher AAB level. Autoimmune processes role (anti-NGF AAB) in formation of RS clinical features is discussed.

[Nerve growth factor auto-antibodies in children with various forms of mental dysontogenesis and in schizophrenia high risk group]. / Autoantitela k faktoru rosta nervov u detei s razlichnymi formami psikhicheskogo dizontogeneza i iz gruppy vysokogo riska po shizofrenii.

The level of autoantibodies (AAb) to nerve growth factor was evaluated in blood serum of 163 children with different forms of mental dysontogenesis of endogenic, residual-organic, psychogenic and deprivative origin. Significant elevation of the level of AAb was found in all forms of psychic dysontogenesis. The most significant elevation of the level of AAb (p < 0.01), as compared with the controls (45 children), was characteristic for endogenic forms of dysontogenesis (schizophrenia, early children's autism, schizotypic diathesis). The level of AAb was also found as an indicator of the acuteness of the pathologic state. Besides, its elevation was observed 1-2 weeks prior to the onset of the clinical exacerbation. Elevation of AAb level was also found in psychic dysontogenesis of residual-organic nature (children with perinatal encephalopathy), but it was not so significant as compared with the controls (p < 0.05%). The analysis in the age dynamics of children from this group revealed, that AAb level may serve as some prognostic index of the severity of psychic dysontogenesis. The level of AAb differs some states in schizotypic diathesis and deprivative dysontogenesis, which are clinically quite similar. The method for the estimation of serum AAb level may be proposed as screening in prophylactic medical examination of children from the first year of life under conditions of pediatric outpatient service for identification of risk-groups by psychic dysontogenesis to perform early special psychoprophylaxis.

Changes in the serum levels of autoantibody to nerve growth factor in patients with schizophrenia.

Studies were performed on 54 patients with different types of schizophrenia-paranoid (8), recurrent-progressive (30), and slowly progressive (16), with ICD-10 rubrics F20.00 and F20.01, F20.22 and F20.02, and F21 respectively. An immunoenzyme method was used to demonstrate that schizophrenia patients had elevated levels of autoantibody to nerve growth factor, by a factor of 1.5 compared with a group of 70 healthy subjects. The autoantibody level was related to the stage of disease: during the active phase, there was a significant increase compared with patients in remission (1.38 +/- 0.26 and 0.92 +/- 0.25 U respectively). There were no differences between variants with different disease courses. The authors suggest that the data obtained here indicate that the autoantibody level can be used as a measure of the activity of the disease process.

[Changes in the level of autoantibodies to the nerve growth factor in the blood serum of schizophrenia patients]. / Izmenenie urovnia autoantitel k faktoru rosta nervov v syvorotke krovi bol'nykh shizofreniei.

A study was made of 54 patients with different forms of schizophrenia: paranoid (8), shift-like (30), slow-progredient (16). According to ICD-10 the rubrics were: F20.00 and F20.01; F20.22 and F20.02; F21 respectively. Elevation of the level of autoantibodies (aAB) to nerve growth factor (NGF) 1,5-fold was registered in blood serum of schizophrenic patients by means of enzyme immunoassay as compared with 70 healthy controls. The dependence of aAB level upon the stage of the disease development was found: in the active phase there was a significant increase of aAB level as compared with the patients in remission (1.38 +/- 0.26 and 0.92 +/- 0.25 units of optical density, respectively). There were no differences in respect of different forms of disease. The authors suggest to use aAB level as the index of the disease activity.

[An elevation in the level of autoantibodies to nerve-growth factor in the blood serum of schizophrenic children]. / Povyshenie urovnia autoantitel k faktoru rosta nervov v syvorotke krovi detei, bol'nykh shizofreniei.

The level of autoantibodies (AAB) to nerve growth factor (NGF) was examined in blood of mentally healthy children, children with early children schizophrenia as well as with Kanner's and Asperger's syndromes too. The elevated titer of AAB to NGF was determined in blood of children with acute, active state of disease; meanwhile the same titer wasn't changed in the state of stable remission or steady defective state as compared with control group. The correlation was found between the level of AAB to NGF and the degree of disease progression. The correlations which were revealed between AAB to NGF level and peculiarities of the clinical state of patients permitted to use this index as the objective marker of both the acuteness and the severity of the patient's state.